Form 4 Filing for Aquestive Therapeutics, Inc. - Insider Transaction

This filing details a stock option grant to Timothy E. Morris, a director at Aquestive Therapeutics, Inc. The grant includes 50,500 stock options for Common Stock, with a purchase price of $3.99 per share. The options vest fully on June 10, 2027, contingent upon Mr. Morris's continuous service to the company. The transaction date is June 10, 2026, and the post-transaction shares owned by Mr. Morris amount to 50,500. Additionally, the filing includes a Power of Attorney document, authorizing specific individuals to act on behalf of the undersigned for SEC filings, including Forms 3, 4, and 5, and Form 144.